Cargando…
Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis
Mycobacterium tuberculosis has been infecting millions of people worldwide over the years, causing tuberculosis. Drugs targeting distinct cellular mechanisms including synthesis of the cell wall, lipids, proteins, and nucleic acids in Mtb are currently being used for the treatment of TB. Although ex...
Autores principales: | Yelamanchi, Soujanya D., Arun Kumar, Sumaithangi Thattai, Mishra, Archita, Keshava Prasad, Thottethodi Subrahmanya, Surolia, Avadhesha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911922/ https://www.ncbi.nlm.nih.gov/pubmed/35268621 http://dx.doi.org/10.3390/molecules27051520 |
Ejemplares similares
-
Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis
por: Yelamanchi, Soujanya D., et al.
Publicado: (2022) -
An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a novel combinatorial therapy
por: Mishra, Archita, et al.
Publicado: (2018) -
Ligand Specificity of Group I Biotin Protein Ligase of Mycobacterium tuberculosis
por: Purushothaman, Sudha, et al.
Publicado: (2008) -
Proteomic analysis of purified protein derivative of Mycobacterium tuberculosis
por: Prasad, Thottethodi Subrahmanya Keshava, et al.
Publicado: (2013) -
Comprehensive insights into Mycobacterium tuberculosis DevR (DosR) regulon activation switch
por: Chauhan, Santosh, et al.
Publicado: (2011)